OPTICAL COHERENCE TOMOGRAPHY, FLUORESCEIN ANGIOGRAPHY, AND DIAGNOSIS OF CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

In a prospective study, spectral domain optical coherence tomography and fluorescein angiography, combined with color fundus photograph used as a first diagnostic test in patients aged 50 years or older, had a similar sensitivity and specificity for the diagnosis of choroidal neovascularization in age-related macular degeneration.

[1]  S. Wolf,et al.  Angiographic findings in patients with exudative age-related macular degeneration , 2002, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  S. J. Talks,et al.  Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes , 2005, British Journal of Ophthalmology.

[3]  Z. Koshy,et al.  Use of optical coherence tomography, fluorescein angiography and indocyanine green angiography in a screening clinic for wet age-related macular degeneration , 2006, British Journal of Ophthalmology.

[4]  William J Feuer,et al.  An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.

[5]  N. Bressler.  Antiangiogenic approaches to age-related macular degeneration today. , 2009, Ophthalmology.

[6]  Philip J Rosenfeld,et al.  A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. , 2009, American journal of ophthalmology.

[7]  R. Zawadzki,et al.  High-resolution Fourier-domain optical coherence tomography of choroidal neovascular membranes associated with age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.

[8]  K Bailey Freund,et al.  Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.

[9]  E. Chew,et al.  Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices , 2009, Eye.

[10]  N. Bressler,et al.  Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. , 2010, Ophthalmology.

[11]  Neovascular age-related macular degeneration: decision making and optimal management , 2010, Eye.

[12]  Joan W. Miller,et al.  Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. , 2011, Investigative ophthalmology & visual science.

[13]  Sandra S Stinnett,et al.  Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. , 2012, Ophthalmology.

[14]  M. Macsai,et al.  PILOT STUDY FOR THE DETECTION OF EARLY EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY , 2012, Retina.

[15]  Sharon D. Solomon,et al.  Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study. , 2012, Ophthalmology.

[16]  Y. Yang,et al.  Optical coherence tomography changes before the development of choroidal neovascularization in second eyes of patients with bilateral wet macular degeneration , 2012, Eye.

[17]  Adnan Tufail,et al.  Evaluation of age-related macular degeneration with optical coherence tomography. , 2012, Survey of ophthalmology.

[18]  D. Do.  Detection of new-onset choroidal neovascularization , 2013, Current opinion in ophthalmology.

[19]  Jesse J. Jung,et al.  The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. , 2014, American journal of ophthalmology.

[20]  Glenn J Jaffe,et al.  Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.

[21]  C. Wykoff,et al.  COMPARISON OF SPECTRAL-DOMAIN AND TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ACTIVITY , 2014, Retina.

[22]  Francesco Bandello,et al.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) , 2014, British Journal of Ophthalmology.

[23]  W. Amoaku,et al.  The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography , 2015, Eye.

[24]  C. Ramsay,et al.  Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review. , 2015, Ophthalmology.

[25]  K Bailey Freund,et al.  A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization. , 2016, Investigative ophthalmology & visual science.

[26]  Philip J. Rosenfeld,et al.  Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration , 2016, Investigative ophthalmology & visual science.

[27]  Francesco Bandello,et al.  Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naïve Quiescent Choroidal Neovascularization. , 2016, American journal of ophthalmology.

[28]  U. Schmidt-Erfurth,et al.  A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration , 2017, Eye.

[29]  Salomon Y. Cohen,et al.  Imaging of Exudative Age-Related Macular Degeneration: Toward a Shift in the Diagnostic Paradigm? , 2017, Retina.